Walleye Capital LLC Sutro Biopharma, Inc. Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $151,670 - $332,650	73,271 New	73,271 $314,000
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $939,506 - $1.4 Million	-173,661 Reduced 90.58%	18,060 $145,000
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $418,992 - $576,215	-81,043 Reduced 29.71%	191,721 $1.06 Million
Q2 2022 Aug 08, 2022	BUY	$3.41 - $8.95 $713,215 - $1.87 Million	209,154 Added 328.81%	272,764 $1.42 Million
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $91,819 - $180,688	-11,802 Reduced 15.65%	63,610 $523,000
Q4 2021 Mar 03, 2022	BUY	$14.25 - $23.53 $1.07 Million - $1.77 Million	75,412 New	75,412 $1.12 Million
Q1 2019 May 15, 2019	SELL	$8.8 - $11.87 $117,876 - $158,998	-13,395 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $200,925 - $203,604	13,395 New	13,395 $201,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.